CureImmune Therapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8755 Ash St Ste 2, Vancouver, British Co...Phone Number
(778) 379-6883Website
www.cureimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CureImmune Therapeutics
CureImmune Therapeutics Inc. is an innovative biopharmaceutical company based in Vancouver, BC, specializing in the development of therapeutic agents for cancer and autoimmune diseases. The company focuses on targeting key regulators of the immune system through its proprietary technology platform, which includes monoclonal antibodies, fusion proteins, and bifunctional agents. CureImmune aims to unlock the power of immunotherapy to provide effective treatments for patients. Their intended clients include individuals suffering from cancer and autoimmune conditions.Explore more
Popular SearchesCureimmune Therapeutics IncCureimmune CorpCureimmune TherapeuticsSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CureImmune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when CureImmune Therapeutics launches new products
Check if CureImmune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
CureImmune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if CureImmune Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CureImmune Therapeutics
Check out if CureImmune Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once CureImmune Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CureImmune Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to CureImmune Therapeutics
Compare insights from companies similar to CureImmune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CureImmune Therapeutics
<$5M
1-10
Private
-
2006
N/A
Company Profile Activity
Activity Insights
CureImmune Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CureImmune Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CureImmune Therapeutics.
CureImmune Therapeutics Tech Stack
A closer look at the technologies used by CureImmune Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CureImmune Therapeutics
Sign Up For FreeTo access detailed company insights
CureImmune Therapeutics Inc. is an innovative biopharmaceutical company based in Vancouver, BC, specializing in the development of therapeutic agents for cancer and autoimmune diseases. The company focuses on targeting key regulators of the immune system through its proprietary technology platform, which includes monoclonal antibodies, fusion prote... Read More
